Team Mosaiques

Mosaiques Diagnostics GmbH (MOS) is the leading company in clinical proteomics aiming at bringing clinical proteomics solutions to the market. MOS offers his innovative capillary electrophoresis-mass spectrometry (CE-MS) technology to academic partners and pharmaceutical companies to identify new protein targets for diagnostic and therapeutic test applications. The company’s strong competitive position and its primary focus on R&D-activities in the field of clinical proteomics is demonstrated by the publication of more than 400 papers in leading clinical and scientific journals and by the fact that MOS has led the consortium that defined standards for clinical proteome analysis. MOS main research activities are identification of disease-specific proteomic markers in human body fluids, development of software solutions to analyse high-dimensional proteomics and bioinformatics data, establishment of proteome maps of human and animal body fluids, and development of peptide marker patterns for diagnostic ready-to-use test applications. MOS also has ample experience in clinical studies. Among the major clinical areas of interest are chronic kidney disease, acute renal failure, cardiovascular diseases (heart failure, coronary artery disease), diagnosis of endocrine cancers, and transplantation-related complications (acute graft-versus-host disease, acute kidney allograft rejection).

Team mosaiques